T52
Pill imprint T52 has been identified as Acetazolamide 125 mg.
Acetazolamide is used in the treatment of mountain sickness / altitude sickness; hydrocephalus; glaucoma; epilepsy; edema (and more), and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy.
Acetazolamide 125 mg is not subject to the Controlled Substances Act.
See also related documents.
Acetazolamide Images
- Imprint:
-
T52
- Strength:
- 125 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
corn starch
gelatin
glycerin
water
magnesium silicate
sodium starch glycolate
magnesium stearate
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
Carbonic anhydrase inhibitors - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Taro Pharmaceuticals U.S.A., Inc.
- National Drug Code (NDC):
- 51672-4022
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-4387 | A S Medication Solutions LLC (repackager) |
| 23490-5007 | Palmetto State Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More Acetazolamide resources
- Acetazolamide (Wolters Kluwer)
- Acetazolamide Solution (Wolters Kluwer)
- Acetazolamide Sustained-Release Capsules (Wolters Kluwer)
- acetazolamide (Cerner Multum)
- Acetazolamide (AHFS DI)
- Acetazolamide Sodium (AHFS DI)
- Acetazolamide (FDA)
- Acetazolamide Capsules (FDA)
- Acetazolamide Tablets (FDA)
- Acetazolamide (Wolters Kluwer)


